TOMMY DOOLEY: Open Payments
NPI 1740709138 · BARBOURSVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 98 payments from 15 companies in 2025. Trend: 2023 $994 · 2024 $1,928 · 2025 $1,735
Food & beverage: $1,519Education: $216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $614 |
| Regeneron Healthcare Solutions, Inc. | 11 | $304 |
| Janssen Biotech, Inc. | 14 | $280 |
| UCB, Inc. | 17 | $199 |
| Galderma Laboratories, L.P. | 3 | $56 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| Organon LLC | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| LEO Pharma Inc. | 1 | $29 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, NEMLUVIO, Zoryve, Sotyktu.
Industry payments across WV — which companies pay providers there.
